Tag: Taxotere
SIGN UP FOR OUR NEWSLETTER


Quick Search

Reset

Chemotherapy in Prostate Cancer

Sat 28 Feb 2009

  By Richard Lam, M.D. Prostate Oncology Specialists, Marina del Rey, CA Edited from PCRI Insights February, 2009 v 12.1 In the last decade, the role of chemotherapy has evolved significantly. The first approved chemotherapy agents, mitoxantrone (Mitoxantrone) and estramustine (Emcyt), were utilized for prostate cancer patients to help control pain and to relieve symptomsRead More ›

Dealing With Taxotere® Side Effects

Thu 31 May 2007

  by Richard Lam, MD Prostate Oncology Specialists, Marina del Rey, CA Edited from PCRI Insights May, 2007 vol. 10, no.2 Overall, Taxotere® is well tolerated. However, successful administration of this powerful medicine requires diligent surveillance so that potential complications can be detected and corrected before they become severe. Introduction Taxotere® (docetaxel) is the mostRead More ›

Dealing With Taxotere® Side Effects

Tue 1 May 2007

by Richard Lam, MD Prostate Oncology Specialists, Marina del Rey, CA Edited from PCRI Insights May, 2007 vol. 10, no.2 Overall, Taxotere® is well tolerated. However, successful administration of this powerful medicine requires diligent surveillance so that potential complications can be detected and corrected before they become severe. Introduction Taxotere® (docetaxel) is the most activeRead More ›

Chemotherapy for Prostate Cancer: "Why Bother?"

Mon 1 May 2006

by Brad Guess, PA-C Executive Director, PCRI Edited from PCRI Insights May, 2006 vol. 9 no.2 Introduction I recently had the opportunity to sit in on a prostate cancer (PC) journal club meeting attended by PC experts from a multitude of medical specialties. The focus of this meeting was the use of chemotherapy in PC,Read More ›

Hormone-Refractory Prostate Cancer: A Continuum of Diseases and Options

Tue 1 Nov 2005

By Oliver Sartor, M.D., Chief, Hematology-Oncology Section; Director, Stanley S. Scott Cancer Center, LSU Medical Center, New Orleans Edited from PCRI Insights November, 2005 vol. 8 no.4 Introduction It is possible that hormones can sometimes cure, but unfortunately, that seems to be true only in a minority of patients. Certainly if the disease has becomeRead More ›

Important Principles in Chemotherapy: Regimens Treating And Androgen-Independent Prostate Cancer (AIPC)

Wed 1 Dec 1999

By Stephen B. Strum, MD Reprinted from PCRI Insights December 1999, vol. 2, no. 4   One of the greatest problems we face today is how to prevent the emergence of AIPC and how to treat it when it develops. AIPC is defined as disease progression evidenced by a progressively rising PSA (three consecutive risesRead More ›